Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage

Xiuwen Guan(Chinese Academy of Medical Sciences & Peking Union Medical College), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Ma(XinHua Hospital), Zongbi Yi(Chinese Academy of Medical Sciences & Peking Union Medical College), Liang Fang, Binliang Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Shaochuan Li(BGI Group (China)), Chunxiao Li, Xiaoying Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Lixi Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Oncology
July 7, 2020
10.3389/fonc.2020.00902
Cited by 52

Related Papers

A human gut microbial gene catalogue established by metagenomic sequencing
|Nature|2010|11.6k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
The diploid genome sequence of an Asian individual
|Nature|2008|960